{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:38:54Z","timestamp":1793194734979,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007771","name":"\u015al\u0105ski Uniwersytet Medyczny","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010252","name":"Medical University of Silesia","doi-asserted-by":"publisher","award":["KNW-2-027\/N\/9\/N"],"award-info":[{"award-number":["KNW-2-027\/N\/9\/N"]}],"id":[{"id":"10.13039\/501100010252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010252","name":"Medical University of Silesia","doi-asserted-by":"publisher","award":["PCN-2-014\/N\/1\/F"],"award-info":[{"award-number":["PCN-2-014\/N\/1\/F"]}],"id":[{"id":"10.13039\/501100010252","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.biopha.2023.114921","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T18:33:40Z","timestamp":1684866820000},"page":"114921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Unfavorable effects of memantine on the skeletal system in female rats"],"prefix":"10.1016","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0542-8471","authenticated-orcid":false,"given":"Piotr","family":"Londzin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"Cegie\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Trawczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenon P.","family":"Czuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4376-2748","authenticated-orcid":false,"given":"Joanna","family":"Folwarczna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.114921_bib1","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.3390\/molecules25174005","article-title":"Memantine derivatives as multitarget agents in Alzheimer\u2019s disease","volume":"25","author":"Marotta","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2023.114921_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123289","article-title":"Memantine monotherapy for Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"10","author":"Matsunaga","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.114921_bib3","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/14740338.2018.1524870","article-title":"The efficacy and safety of memantine for the treatment of Alzheimer\u2019s disease","volume":"17","author":"Matsunaga","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.biopha.2023.114921_bib4","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.braindev.2021.05.012","article-title":"A retrospective analysis of memantine use in a pediatric neurology clinic","volume":"43","author":"Bouhadoun","year":"2021","journal-title":"Brain Dev."},{"key":"10.1016\/j.biopha.2023.114921_bib5","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/brain\/awad018","article-title":"Memantine: a novel treatment for children with developmental and epileptic encephalopathies","volume":"146","author":"Whitney","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2023.114921_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2019.112602","article-title":"A systematic review and meta-analysis: memantine augmentation in moderate to severe obsessive-compulsive disorder","volume":"282","author":"Modarresi","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.biopha.2023.114921_bib7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2023.114921_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174455","article-title":"Memantine and its benefits for cancer, cardiovascular and neurological disorders","volume":"910","author":"Shafiei-Irannejad","year":"2021","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2023.114921_bib9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3233\/JAD-170424","article-title":"Memantine for Alzheimer\u2019s disease: an updated systematic review and meta-analysis","volume":"60","author":"Kishi","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.biopha.2023.114921_bib10","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.tips.2016.05.012","article-title":"Physiological roles of non-neuronal NMDA receptors","volume":"37","author":"Hogan-Cann","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2023.114921_bib11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jemt.10120","article-title":"Glutamatergic innervation in bone","volume":"58","author":"Chenu","year":"2002","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.biopha.2023.114921_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fendo.2012.00089","article-title":"Glutamate signaling in healthy and diseased bone","volume":"3","author":"Cowan","year":"2012","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.biopha.2023.114921_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2008.04.060","article-title":"Regulation of the maturation of osteoblasts and osteoclastogenesis by glutamate","volume":"589","author":"Lin","year":"2008","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2023.114921_bib14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/138945007780618472","article-title":"Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation","volume":"8","author":"Lipton","year":"2007","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.biopha.2023.114921_bib15","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2174\/157015912803217288","article-title":"NMDA neurotransmission dysfunction in behavioral and psychological symptoms of Alzheimer\u2019s disease","volume":"10","author":"Huang","year":"2012","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.biopha.2023.114921_bib16","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.biocel.2006.11.002","article-title":"Current perspectives on NMDA-type glutamate signalling in bone","volume":"39","author":"Spencer","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2023.114921_bib17","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1254\/jphs.FM0070243","article-title":"Pharmacological topics of bone metabolism: glutamate as a signal mediator in bone","volume":"106","author":"Takarada","year":"2008","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2023.114921_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bone.2003.10.016","article-title":"Mechanical loading modulates glutamate receptor subunit expression in bone","volume":"37","author":"Szczesniak","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2023.114921_bib19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/aps.2011.38","article-title":"Multiple signaling pathways involved in stimulation of osteoblast differentiation by N-methyl-D-aspartate receptors activation in vitro","volume":"32","author":"Li","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2023.114921_bib20","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1096\/fj.02-0820fje","article-title":"Modulation of cellular differentiation by N-methyl-D-aspartate receptors in osteoblasts","volume":"17","author":"Hinoi","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2023.114921_bib21","first-page":"285","article-title":"Osteoblastic glutamate receptor function regulates bone formation and resorption","volume":"2","author":"Taylor","year":"2002","journal-title":"J. Musculoskelet. Neuron Interact."},{"key":"10.1016\/j.biopha.2023.114921_bib22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jcb.10625","article-title":"NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis","volume":"90","author":"Merle","year":"2003","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2023.114921_bib23","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1096\/fasebj.13.15.2179","article-title":"The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation","volume":"13","author":"Peet","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2023.114921_bib24","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1007\/s00198-005-1928-y","article-title":"Down-regulation of N-methyl D-aspartate receptor in rat-modeled disuse osteopenia","volume":"16","author":"Ho","year":"2005","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.biopha.2023.114921_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.job.2020.03.003","article-title":"Effects of N-methyl-D-aspartate receptor antagonist MK-801 (dizocilpine) on bone homeostasis in mice","volume":"62","author":"Kiyohara","year":"2020","journal-title":"J. Oral. Biosci."},{"key":"10.1016\/j.biopha.2023.114921_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1517\/14728222.2014.983900","article-title":"The potential of targeting NMDA receptors outside the CNS","volume":"19","author":"Bozic","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2023.114921_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/bbrc.2000.2097","article-title":"Specific antagonists of NMDA receptors prevent osteoclast sealing zone formation required for bone resorption","volume":"268","author":"Itzstein","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2023.114921_bib28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3233\/JAD-201137","article-title":"Effect of memantine treatment and combination with vitamin D supplementation on body composition in the APP\/PS1 mouse model of Alzheimer\u2019s disease following chronic vitamin D deficiency","volume":"81","author":"Wong","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.biopha.2023.114921_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109139","article-title":"Effects of (R)-ketamine on reduced bone mineral density in ovariectomized mice: a role of gut microbiota","volume":"213","author":"Wan","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2023.114921_bib30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41380-021-01121-1","article-title":"Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor","volume":"27","author":"Wei","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.biopha.2023.114921_bib31","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1038\/mp.2017.109","article-title":"Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder","volume":"23","author":"Kadriu","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.biopha.2023.114921_bib32","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/ijnp\/pyx100","article-title":"Role of inflammatory bone markers in the antidepressant actions of (R)-ketamine in a chronic social defeat stress model","volume":"21","author":"Zhang","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2023.114921_bib33","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/jcb.25772","article-title":"Clinically relevant concentrations of ketamine inhibit osteoclast formation in vitro in mouse bone marrow cultures","volume":"118","author":"Du","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2023.114921_bib34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/npr2.12132","article-title":"Decreased bone mineral density in ovariectomized mice is ameliorated after subsequent repeated intermittent administration of (R)-ketamine, but not (S)-ketamine","volume":"40","author":"Fujita","year":"2020","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.biopha.2023.114921_bib35","first-page":"338","article-title":"Identification of N-methyl-D-aspartate receptor subunit in human periodontal ligament fibroblasts: Potential role in regulating differentiation","volume":"80","author":"Yu","year":"2009","journal-title":"J. Periodo"},{"key":"10.1016\/j.biopha.2023.114921_bib36","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/pds.4232","article-title":"Screening approach for identifying candidate drugs and drug-drug interactions related to hip fracture risk in persons with Alzheimer disease","volume":"26","author":"Tolppanen","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.biopha.2023.114921_bib37","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1532-5415.2011.03450.x","article-title":"Dementia medications and risk of falls, syncope, and related adverse events meta-analysis of randomized controlled trials","volume":"59","author":"Kim","year":"2011","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.biopha.2023.114921_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116137","article-title":"Associations between osteoporosis and drug exposure: A post-marketing study of the World Health Organization pharmacovigilance database (VigiBase\u00ae","volume":"153","author":"Batteux","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2023.114921_bib39","doi-asserted-by":"crossref","first-page":"8991","DOI":"10.3390\/ijms24108991","article-title":"Effects of donepezil on the musculoskeletal system in female rats","volume":"24","author":"Londzin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114921_bib40","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/ph15080915","article-title":"Effect of administration of azithromycin and\/or probiotic bacteria on bones of estrogen-deficient rats","volume":"15","author":"Cegie\u0142a","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2023.114921_bib41","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/mnfr.201300123","article-title":"Favorable effect of moderate dose caffeine on the skeletal system in ovariectomized rats","volume":"57","author":"Folwarczna","year":"2013","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.biopha.2023.114921_bib42","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3390\/nu10111701","article-title":"Phloridzin, an apple polyphenol, exerted unfavorable effects on bone and muscle in an experimental model of type 2 diabetes in rats","volume":"10","author":"Londzin","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2023.114921_bib43","doi-asserted-by":"crossref","first-page":"2793804","DOI":"10.1155\/2020\/2793804","article-title":"Negligible effect of estrogen deficiency on development of skeletal changes induced by type 1 diabetes in experimental rat models","volume":"2020","author":"Janas","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2023.114921_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113679","article-title":"Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic rats","volume":"155","author":"Londzin","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.114921_bib45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1359\/JBMR.050913","article-title":"Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibias of the rat: effect of estradiol, testosterone, and raloxifene","volume":"21","author":"St\u00fcrmer","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.biopha.2023.114921_bib46","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/8756-3282(93)90081-K","article-title":"Basic biomechanical measurements of bone: a tutorial","volume":"14","author":"Turner","year":"1993","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2023.114921_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/jbmr.5650030107","article-title":"Bone status of senescent male rats: chemical, morphometric, and mechanical analysis","volume":"3","author":"Kiebzak","year":"1988","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.biopha.2023.114921_bib48","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1359\/jbmr.1997.12.11.1903","article-title":"Comparison of bone density measurement techniques: DXA and Archimedes\u2019 principle","volume":"12","author":"Keenan","year":"1997","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.biopha.2023.114921_bib49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res"},{"key":"10.1016\/j.biopha.2023.114921_bib50","first-page":"433","article-title":"Effects of doxycycline on development of changes in histomorphometric parameters of bones induced by bilateral ovariectomy in rats","volume":"55","author":"Folwarczna","year":"2003","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114921_bib51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuroscience.2014.05.011","article-title":"Memantine improves spatial learning and memory impairments by regulating NGF signaling in APP\/PS1 transgenic mice","volume":"273","author":"Liu","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2023.114921_bib52","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neulet.2013.02.065","article-title":"Xanthoceraside attenuates learning and memory deficits via improving insulin signaling in STZ-induced AD rats","volume":"543","author":"Liu","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2023.114921_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145441","article-title":"Memantine attenuates Alzheimer\u2019s disease-like pathology and cognitive impairment","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.114921_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.153937","article-title":"Xanthoceraside exerts anti-Alzheimer\u2019s disease effect by remodeling gut microbiota and modulating microbial-derived metabolites level in rats","volume":"98","author":"Zhou","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2023.114921_bib55","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13195-018-0457-9","article-title":"Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer\u2019s disease: a network meta-analysis of 41 randomized controlled trials","volume":"10","author":"Dou","year":"2018","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.biopha.2023.114921_bib56","first-page":"624","article-title":"The laboratory rat: relating its age with human\u2019s","volume":"4","author":"Sengupta","year":"2013","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.biopha.2023.114921_bib57","doi-asserted-by":"crossref","first-page":"287","DOI":"10.18388\/abp.2015_1095","article-title":"Effect of diosgenin, a steroidal sapogenin, on the rat skeletal system","volume":"63","author":"Folwarczna","year":"2016","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.biopha.2023.114921_bib58","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pharep.2013.08.010","article-title":"Modifications of histamine receptor signaling affect bone mechanical properties in rats","volume":"66","author":"Folwarczna","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.biopha.2023.114921_bib59","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000329551","article-title":"The N-methyl-D-aspartic acid receptor antagonist memantine ameliorates and delays the development of arthritis by enhancing regulatory T cells","volume":"20","author":"Lindblad","year":"2012","journal-title":"Neurosignals"},{"key":"10.1016\/j.biopha.2023.114921_bib60","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7150\/ijbs.13815","article-title":"Ebselen is a potential anti-osteoporosis agent by suppressing receptor activator of nuclear factor kappa-B ligand-induced osteoclast differentiation in vitro and lipopolysaccharide-induced inflammatory bone destruction in vivo","volume":"12","author":"Baek","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2023.114921_bib61","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.joca.2009.02.002","article-title":"Glutamate signaling in chondrocytes and the potential involvement of NMDA receptors in cell proliferation and inflammatory gene expression","volume":"17","author":"Piepoli","year":"2009","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.biopha.2023.114921_bib62","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.biopha.2017.04.054","article-title":"Memantine inhibits degradation of the articular cartilage extracellular matrix induced by advanced glycation end products (AGEs","volume":"91","author":"Zhao","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.114921_bib63","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1213\/01.ANE.0000117141.76392.65","article-title":"Intraarticular pretreatment with ketamine and memantine could prevent arthritic pain: relevance to the decrease of spinal c-Fos expression in rats","volume":"99","author":"Zhang","year":"2004","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.biopha.2023.114921_bib64","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/labinvest.2015.142","article-title":"Wnt signaling in cartilage development and diseases: Lessons from animal studies","volume":"96","author":"Usami","year":"2016","journal-title":"Lab. Invest."},{"key":"10.1016\/j.biopha.2023.114921_bib65","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bone.2018.11.002","article-title":"Use it or lose it to age: a review of bone and muscle communication","volume":"120","author":"Bonewald","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2023.114921_bib66","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00198-018-4570-1","article-title":"Impact of muscle atrophy on bone metabolism and bone strength: Implications for muscle-bone crosstalk with aging and disuse","volume":"29","author":"Bettis","year":"2018","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.biopha.2023.114921_bib67","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: Beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2023.114921_bib68","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00005-014-0285-y","article-title":"Distinct VEGF functions during bone development and homeostasis","volume":"62","author":"Liu","year":"2014","journal-title":"Arch. Immunol. Ther. Exp. (Warsz. )."},{"key":"10.1016\/j.biopha.2023.114921_bib69","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1167\/iovs.07-0427","article-title":"Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats","volume":"48","author":"Kusari","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2023.114921_bib70","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12974-020-01913-2","article-title":"Memantine ameliorates motor impairments and pathologies in a mouse model of neuromyelitis optica spectrum disorders","volume":"17","author":"Yick","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2023.114921_bib71","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12031-017-0974-1","article-title":"Neovascularization and synaptic function regulation with memantine and rosuvastatin in a rat model of chronic cerebral hypoperfusion","volume":"63","author":"Zhang","year":"2017","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2023.114921_bib72","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.3892\/mmr.2020.11543","article-title":"Cytokines CCL2 and CXCL1 may be potential novel predictors of early bone loss","volume":"22","author":"Hu","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2023.114921_bib73","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s11914-019-00545-7","article-title":"Monocyte chemoattractant protein-1 (MCP-1\/CCL2) drives activation of bone remodelling and skeletal metastasis","volume":"17","author":"Mulholland","year":"2019","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.biopha.2023.114921_bib74","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.3389\/fimmu.2019.02182","article-title":"Chemokines in physiological and pathological bone remodeling","volume":"10","author":"Brylka","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2023.114921_bib75","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/jcb.25282","article-title":"CCL2 and CCR2 are essential for the formation of osteoclasts and foreign body giant cells","volume":"117","author":"Khan","year":"2016","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2023.114921_bib76","doi-asserted-by":"crossref","first-page":"468","DOI":"10.7555\/JBR.31.20150166","article-title":"CC chemokines CCL2, CCL3, CCL4 and CCL5 are elevated in osteoporosis patients","volume":"31","author":"Fatehi","year":"2017","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.biopha.2023.114921_bib77","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12979-019-0155-x","article-title":"Inflammatory markers and bone health in postmenopausal women: a cross-sectional overview","volume":"16","author":"Ilesanmi-Oyelere","year":"2019","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.biopha.2023.114921_bib78","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijge.2018.03.007","article-title":"Association between osteoporosis, bone mineral density levels and Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"12","author":"Lv","year":"2018","journal-title":"Int. J. Gerontol."},{"key":"10.1016\/j.biopha.2023.114921_bib79","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/03008207.2019.1624734","article-title":"Mechanistic complexities of bone loss in Alzheimer\u2019s disease: a review","volume":"61","author":"Frame","year":"2020","journal-title":"Connect. Tissue Res."},{"key":"10.1016\/j.biopha.2023.114921_bib80","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1007\/s12035-016-9841-2","article-title":"Alzheimer\u2019s disease is an important risk factor of fractures: a meta-analysis of cohort studies","volume":"54","author":"Liang","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2023.114921_bib81","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5606\/tftrd.2020.3803","article-title":"Low bone density and osteoporosis among older adults with Alzheimer\u2019s disease, vascular dementia, and mixed dementia: a cross-sectional study with prospective enrollment","volume":"66","author":"Ba\u015fg\u00f6z","year":"2020","journal-title":"Turk. J. Phys. Med. Rehabil."},{"key":"10.1016\/j.biopha.2023.114921_bib82","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/tcmj.tcmj_54_17","article-title":"Alzheimer\u2019s disease and osteoporosis","volume":"29","author":"Chen","year":"2017","journal-title":"Tzu Chi Med. J."},{"key":"10.1016\/j.biopha.2023.114921_bib83","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JAD-2010-101467","article-title":"Association between bone mineral density and the risk of Alzheimer\u2019s disease","volume":"24","author":"Zhou","year":"2011","journal-title":"J. Alzheimer\u2019s Dis."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223007114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223007114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:22:25Z","timestamp":1793193745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223007114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":83,"alternative-id":["S0753332223007114"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114921","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unfavorable effects of memantine on the skeletal system in female rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114921","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114921"}}